Measles Outbreak Cases Cross 100 Mark In US, Australia Sees Sudden Surge Of The Infectious Disease

Updated Feb 23, 2025 | 11:46 AM IST

SummaryMeasles continues to create havoc with over 100 people infected in US. New health guidelines and advisories are being issued to ensure people remain safe and vigilant.
(Credit-Canva)

(Credit-Canva)

The current measles outbreak has gripped US states like Texas and New Mexico leaving people worried whether it would become a new pandemic. According to the Texas Department of State Health Services as of February 21, 90 cases were diagnosed in the last month in the South Plains area, with at least 77 of them were reported in children and teens under 17.

Measles is highly contagious and can be deadly. The outbreak, which started spreading in late January, has resulted in multiple hospitalizations, with at least nine confirmed cases and three probable cases as of early February. Health officials caution that at least one in five infected individuals will have to be hospitalized, highlighting the severity of the situation.

Misinformation surrounding vaccines and with the new Trump administration anti-vaccine campaigs, has causing parents to hesitate or refuse vaccination.

Furthermore, the country down under Australia is also witnessing a surge in measles cases as health officials in Sydney have issued an urgent alert, urging residents to watch for measles symptoms after an infected individual visited several places in Sydney over the last seven days.

Authorities report that the traveller had returned from South East Asia where there are ongoing outbreaks of measles.

What Are The Symptoms Measles?

Key symptoms of measles include fever, a runny nose, sore eyes, and a cough. Typically, a red, blotchy rash appears three to four days later, spreading from the head down to the body. Symptoms can manifest between 7 and 18 days after exposure.

Anyone who experiences these symptoms after potential exposure should immediately contact their doctor or emergency department. It is crucial to call ahead before visiting to avoid potentially exposing others in the waiting room. Dr. Selvey also highlighted that ongoing measles outbreaks are occurring in various parts of the world, making awareness and prompt action essential.

Why It Is Important To Get Vaccinated?

According to CDC everyone should get the MMR vaccine. It protects you from measles, mumps, and rubella. Getting vaccinated helps stop these diseases from spreading. There are two safe MMR vaccines available. They work the same way, so it doesn't matter which one you get. Kids can also get a shot that protects against chickenpox too, but this is only for children.

Who Should Get Vaccinated?

Kids Need Two Shots

All children should get two MMR shots. The first shot should be given when they are between 12 and 15 months old. The second shot should be given when they are between 4 and 6 years old. If needed, the second shot can be given earlier, but it must be at least 28 days after the first shot.

College Students Need to Be Protected

Students going to college or other schools after high school, need two shots if they are not already immune. The shots must be at least 28 days apart.

Adults Need at Least One Shot

Most adults need at least one MMR shot. Some adults need two shots, especially those who work in healthcare, travel a lot, or go to college. These people should get two shots, with 28 days between them.

Travelers Need to Be Extra Careful

Anyone traveling to other countries should make sure they are protected. Babies 6 to 11 months old should get one shot before traveling. Kids 12 months and older, teens, and adults need two shots, with 28 days between them.

Healthcare Workers Must Be Immune

People who work in healthcare should have proof that they are immune to measles, mumps, and rubella. If they are not immune, they need two MMR shots, spaced 28 days apart.

Women Thinking About Having Babies

Women who might get pregnant should talk to their doctor about the MMR vaccine. It's safe to get the shot while breastfeeding.

End of Article

Barry Manilow Is Diagnosed With Lung Cancer At 82

Updated Dec 23, 2025 | 07:16 AM IST

SummaryBarry Manilow, 82, revealed he has been diagnosed with lung cancer after tests for prolonged bronchitis found an early cancerous spot on his left lung. Doctors say it has not spread and surgery is planned, with no chemotherapy or radiation expected. His January concert dates may be postponed during recovery period.
Barry Manilow Is Diagnosed With Lung Cancer At 82

Credits: Wikimedia Commons

Barry Manilow, singer, has been diagnosed with lung cancer and will be undergoing a surgery for the same. He announced this update on his social media post on Monday. Currently 82, he said he had been fighting bronchitis for more than two months, and it was when his doctor ordered an MRI that the test "discovered a cancerous spot on my left lung that needs to be removed. It is pure luck (and a great doctor) that it was found so early."

He said that doctors do not think that the cancer had spread and that he will have additional tests to confirm the diagnosis.

“No chemo, No radiation. Just chicken soup and I Love Lucy reruns,” he wrote.

However, Manilow did not mention when he would be having the surgery, however, he is expected to rest for a month to fully recover from it. This means the nine concert dates that are scheduled for January could be postponed. “Just like you, we were all looking forward to the January shows and hate having to move everything around,” he wrote. However, no other information on the rescheduled concert dates were provided.

What Is Lung Cancer?

As per the Centers for Disease Control and Prevention (CDC), lung cancer begins in the lungs and may spread to lymph nodes or other organs in the body, including brain too, if not caught early. Cancer cells from other organs too could spread to the lungs, this process is called metastases.

In lung cancer, uncontrolled growth of abnormal cells in the lung tissues, usually in the lining of air passages, forms tumors that disrupt normal breathing and can spread to other parts of the body. This is also the leading cause of cancer death.

There are several types of cancer, and in lung cancer, there are two main types called:

  • Small cell Cancer
  • Non-small Cell cancers: including adenocarcinoma, squamous cell carcinoma, and large cell carcinoma

These types of cancer grow differently and are treated differently. Non-small cell lung cancer is more common than small cell lung cancer. Manilow, however, did not specify the type of lung cancer he has been diagnosed with, neither did he mention the stage of lung cancer he has been diagnosed with. However, he did note that the cancerous spots were found early on.

Read: Did Scientists Just Come Up With A New Blood Test That Detects And Monitors Lung Cancers In Real Time?

What Are The Common Symptoms Of Lung Cancer?

No cancer journey is the same, so people too ca have different symptoms for lung cancers. Some people may have symptoms related to lung cancer, whereas others won't feel a thing until it has spread to other parts of the body. Some people just have general symptoms of not feeling well. However, there are certain common symptoms that some people may experience, they include:

  • Coughing that gets worse or doesn't go away.
  • Chest pain.
  • Shortness of breath.
  • Wheezing.
  • Coughing up blood.
  • Feeling very tired all the time.
  • Weight loss with no known cause.

Other changes that can sometimes occur with lung cancer may include repeated bouts of pneumonia and swollen or enlarged lymph nodes (glands) inside the chest in the area between the lungs.

If you experience any of these signs, it is best that you speak to your doctor and get your tests done.

End of Article

FDA Approves Wegovy Pill For Weight Loss; What Difference Does It Make?

Updated Dec 23, 2025 | 06:55 AM IST

SummaryThe US FDA has approved a daily Wegovy pill containing semaglutide, expanding weight loss treatment beyond injections. Available by prescription from January, it shows similar effectiveness and side effects as the shot. With rising GLP-1 use, competition is growing as Eli Lilly prepares rival oral drugs for obesity care nationwide soon.
FDA Approves Wegovy Pill For Weight Loss; What Difference Does It Make?

Credits: iStock

Wegovy pill is now approved by the US Food and Drug Administration (FDA). On Monday, the FDA approved a daily pill version of Novo Nordisk's weight loss drug Wegovy, which is now introducing a new option for patients, that is said to revolutionize weight loss medicine and obesity treatment.

The weight loss pill uses the same active ingredient. semaglutide. The same active ingredient powers the original Wegovy and sister drug for diabetes, Ozempic. Rival company Eli Lilly is also in the process of getting its weight loss drug approved, which will be out in the market by 2026, the CEO had said. Eli Lilly is known for drugs like Zepbound and Mounjaro. In the US, notes health policy research group KFF, at least 1 in 8 Americans are currently taking one of these medicines.

Wegovy Pill's Benefits And When Can People Buy It?

The Wegovy pill showed similar weight loss results as well as the side effects as in the Wegovy shot. The drug will be available by prescription in the US by January, said Novo Nordisk. Dr Jason Brett, who is the principal US medical head for Novo Nordisk told CNN in an interview, "We believe it will expand access and options for patients. We know there are some patients who just won’t take an injectable medication.”

The starting dose of the weight loss Wegovy pill will cost $149 for patients who will be paying out of the pocket. This is under the November agreement announced by the Trump administration. The drug will become pricier via self-pay as doses increase, though Novo Nordisk has not disclosed its prices yet. Patients whose insurance covers the medicines will be paying a lower copay.

The Wegovy weight loss pill is one of the two GLP-1 pill which will hit the market, along with Eli Lilly's orforglipron.

Read: Oral Weight Loss Pill Comes Next Year, Says Eli Lily As It Announces A Third Manufacturing Facility In US

Whose Weight Loss Pill Is More Effective?

While the pills have not been compared head to head in an clinical trial, there have been separate studies done on them. The Wegovy pill showed an average weight loss of 14% over 64 weeks, when compared for a placebo, which showed 2% weight loss. Whereas, orforglipron showed 11% weight loss over 72 weeks on its highest dose, as compared to 2% with placebo.

Wegovy injection on the other hand showed a weight loss of 15%, whereas, Zepbound showed 21% on his highest dose. Placebo remained at 2% and 3%, respectively in comparison with both the drugs.

What Changes And What Remains The Same On Weight Loss Drug?

Side effects, including gastrointestinal issues like nausea and vomiting remain the most common ones with GLP-1 drugs, which was also seen in the studies of the pill as well. The clinical studies showed that 7% of participants on Wegovy pill stopped the treatment because of side effects, verss 6% on placebo. In orforglipron's study, up to 10% of patients stopped treatment, as compared with 3% on placebo.

The key difference with the pill is that it must be taken on an empty stomach with a small amount of water, and patients are not directed to eat, drink, or take any other medicines for the next 30 minutes after taking it.

Doctors have pointed out that a pill version of semgalutide approved for diabetes called Rybelus has not been used as widely as Ozempic in part because of these restrictions. Eli Lilly however says that in clinical trials, orforglipron was taken once a day at any time, without restrictions on food or water.

End of Article

Flu, Covid And RSV ‘Tripledemic’ Drives A Sharp Rise In US Hospitalisations

Updated Dec 22, 2025 | 07:00 PM IST

SummaryWith Christmas approaching, US is facing a “tripledemic” of flu, COVID, and RSV, causing rising hospitalisations. Learn about symptoms, H3N2 subclade K, RSV risks, and prevention tips.
flu tripledemic

Credits: Canva

With Christmas only a week away, doctors are raising alarms over a growing “tripledemic” spreading across New York. Data shared by Northwell Health on Long Island shows a worrying rise across the state. RSV cases have increased by 35 percent, COVID cases by 15 percent, and flu has surged the most, with hospital admissions jumping 75 percent in just one week.

Flu Rising Faster This Year Compared To 2024, Doctors Say

The festive season often brings family gatherings and travel, but it also creates the perfect setting for respiratory viruses to spread. In New York, flu, RSV and COVID cases have climbed steadily since Thanksgiving, and doctors believe numbers will continue to rise through the holidays. “Flu is increasing much faster than what we saw last year,” said Dwayne Breining, senior vice president of lab services at Northwell Health. Speaking to ABC News, Farber added that he has not seen deaths among vaccinated patients, while many severe cases involved people who were unvaccinated.

Flu season usually lasts until early spring, which means doctors say getting vaccinated now can still offer protection. Health experts also emphasise simple but effective habits such as washing hands regularly, wearing a mask if unwell, and skipping holiday events when sick to reduce the risk of spreading infections.

Flu Symptoms You Need To Take Note Of

Common flu symptoms include a sudden fever, chills, muscle pain, headache, extreme tiredness, cough, sore throat, and a blocked or runny nose, often appearing quickly. In some cases, especially among children, vomiting or diarrhoea may also occur. Emergency warning signs include difficulty breathing, chest pain, severe dizziness, confusion, or symptoms that seem to improve but then return and worsen. These signs need urgent medical care, according to the CDC.

What Is H3N2 Subclade K?

H3N2 Subclade K is a more altered version of the influenza A (H3N2) virus, a strain already linked to more severe illness compared to others. A subclade signals genetic changes in the virus, which may help it spread more easily or partially evade immunity gained from past infections or vaccinations.

What Is RSV?

RSV, short for Respiratory Syncytial Virus, is a highly contagious virus that commonly causes respiratory infections. While it often feels like a mild cold, it can lead to serious breathing issues in infants, older adults, and people with weakened immunity. The virus affects the nose, throat and lungs. Most children catch RSV by the age of two, but repeat infections are common. Symptoms include cough, runny nose, fever and wheezing, and medical help is needed if breathing becomes difficult.

Nearly 5 Million Flu Illnesses Reported So Far Nationally

New York City is currently reporting some of the highest flu-like illness levels in the country. States such as Alabama, Colorado, Connecticut, Hawaii, Louisiana, Maryland, Minnesota, New Hampshire, New Jersey, Ohio, Rhode Island and Texas are seeing moderate respiratory illness activity. All other states remain at low or very low levels. The CDC estimates that this flu season has already resulted in at least 4.6 million illnesses, around 49,000 hospitalisations and approximately 1,900 deaths nationwide.

End of Article